# V1 Empirics Check — openai/gpt-5.1-codex-mini (Variant C)

**Model:** openai/gpt-5.1-codex-mini
**Variant:** C
**Date:** 2026-03-13T10:57:40.205545

---

**Idea Fidelity**

The paper follows the manifest closely. It exploits the staggered adoption of EV registration fees across states (2012–2024), uses the AFDC/DOE Experian registration data, and applies a Callaway–Sant’Anna DiD to estimate the causal effect on EV adoption. The dose-response motivation, the PHEV placebo, and the welfare discussion also echo the original design. The most notable divergence is that the empirical section stops short of presenting detailed event-study plots or a full dose-response analysis (the continuous-fee specification is probed with TWFE and carries the wrong sign), but the core research question, identification strategy, and data sources are intact.

**Summary**

The paper provides the first staggered DiD estimate of the effect of state EV-specific registration fees on battery-electric vehicle (BEV) adoption. Using Callaway–Sant’Anna with 400 state-year observations (2016–2023), it reports a point estimate of −0.112 log points for BEV registrations—suggesting approximately an 11 percent reduction—though the coefficient is statistically insignificant (p=0.14). A placebo on PHEVs returns a much smaller, insignificant effect, supporting the interpretation that the fees operate through the BEV-specific cost channel.

**Essential Points**

1. **Outcome Choice and Interpretation:** The paper uses cumulative BEV stocks as the outcome. By construction, these stocks reflect past purchases that were made long before the fee could have any effect, so any treatment effect is necessarily attenuated and delayed. This makes the 11 percent effect hard to interpret economically and raises concerns about timing: did the fee slow new purchases, or simply reduce the flow of registrations that would have occurred later? Replace or supplement the cumulative stock with annual flows (new registrations or sales) if possible, or at least model the dynamics explicitly to show that the treatment effect emerges at an appropriate horizon.

2. **Parallel Trends and Dynamics:** The paper leans heavily on the Callaway–Sant’Anna framework but does not present cohort-specific event studies, lead coefficients, or formal pre-trend diagnostics. Without this, the parallel-trends assumption remains a black box, especially given the substantial heterogeneity in both timing and baseline EV penetration. Provide event-study plots aggregated by cohort (or at least average leads/lags) and report placebo lead coefficients. If some cohorts have too short pre-periods, acknowledge which ones do and either drop them or show robustness to their exclusion.

3. **Dose-Response Specification and Mechanism:** The manifest emphasizes exploiting variation in fee amounts ($50–$250), but the paper’s own dose-response test (TWFE with fee intensity) has the wrong sign and is statistically insignificant. This undermines the "stick intensity matters" narrative. Re-estimate the dose-response within the heterogeneity-robust DiD framework (e.g., by interacting treatment with normalized fee amount in a CS-DiD setting or by modeling a continuous treatment using doubly robust DiD techniques). If the data genuinely lack power to detect intensity effects, explicitly acknowledge this limitation and reframe the mechanism discussion accordingly.

If more than these three issues need substantive attention, the paper is not yet ready for publication.

**Suggestions**

1. **Dynamic Evidence and Event Studies.**  
   - Plot the cohort-period ATT estimates (or aggregated event-time estimates) from the Callaway–Sant’Anna procedure. Showing the pattern of treatment effects over time, including leads, will greatly enhance credibility and allow readers to see whether any pre-trends exist.  
   - Report average lead coefficients (e.g., event time −2, −1) with confidence intervals. If some cohorts have no pre-period, consider trimming them or reporting results with those cohorts excluded.

2. **Address Cumulative Stock Limitations.**  
   - If feasible, switch the outcome to annual net additions to the BEV fleet (new registrations per year), which respond contemporaneously to the fee. If the AFDC data do not report flows, consider differencing the cumulative stocks to approximate flows, while carefully accounting for mechanical autocorrelation.  
   - Alternatively, model the cumulative stock as a dynamic process (e.g., include lagged dependent variables or present estimates of the implied flow effect based on assumed vehicle lifetimes). Explicitly discuss how long it takes a fee change to be reflected in the cumulative count.

3. **Control for Time-Varying Confounders More Fully.**  
   - Beyond population and gasoline consumption, consider including additional time-varying state factors such as GDP per capita, average electricity prices, gasoline prices, or state-level adoption of complementary EV policies (rebates, charging infrastructure subsidies, ZEV mandates). If the data are limited, justify their omission and show robustness (e.g., include linear time trends interacted with regions or state-specific linear trends).  
   - For the dose-response analysis, weight the continuous fee variable by the cohort or state average EV registrations to reflect the economic significance of a given dollar increase.

4. **Clarify Standard Error Inference.**  
   - With 50 clusters, the state-clustered standard errors are reasonable, but the text should state explicitly that wild-cluster bootstrap inference was considered (as mentioned in the manifest) and justify any divergence between bootstrap and standard cluster-robust SEs. If the ATT estimator’s standard errors already use a robust variance (e.g., Abadie-style with clustering), cite the relevant reference and describe how many bootstrap repetitions were run, if any.

5. **Interpret Magnitudes More Carefully.**  
   - The 11 percent point estimate is not statistically significant, yet it is interpreted as policy-relevant. Pair this with a Figure or table that translates the effect into tangible quantities, such as the number of BEVs foregone per state for a representative fee, along with confidence intervals.  
   - When comparing environmental costs to revenue, make the assumptions explicit (fleet size, vehicle miles, carbon intensity) and present a sensitivity analysis showing how the net welfare conclusion changes across plausible parameter values. Use this to underscore that the welfare argument is illustrative, not definitive.

6. **Reconcile Dose-Response with Placebo Results.**  
   - The PHEV placebo is a strength. Extend this placebo by interacting the fee with state-level shares of BEVs vs. PHEVs to see if the treatment effect is concentrated where BEVs are dominant.  
   - For the continuous treatment, consider constructing an instrumented version of the fee magnitude (e.g., using legislative timing or fiscal shortfall indicators as predictors) if endogeneity of fee size is a concern.

7. **Transparency and Replicability.**  
   - Provide the code or pseudo-code for the Callaway–Sant’Anna implementation. Mention the software package (e.g., `did` in R or `csdid` in Stata) and specify any tuning parameters (e.g., type of propensity score model, covariates used).  
   - If there are any missing data or adjustments to the policy timing (e.g., delays between enactment and implementation), document these in the appendix.

8. **Narrative Tone & Uncertainty.**  
   - The paper currently frames the result as “suggestive yet informative,” which is appropriate. Still, temper statements in policy sections (e.g., welfare comparisons) so they emphasize the uncertainty around the estimate rather than treating the point estimate as precise.  
   - In the conclusion, suggest concrete avenues for future research (e.g., using vehicle-level surveys, exploiting county-level policy heterogeneity) to signal that the imprecision is an entry point, not a dead end.

Implementing these suggestions will strengthen the empirical credibility, clarify the economic narrative, and better align the paper with the standards of empirical policy research.
